Upgrade to enjoy subscriber-only features like email alerts and data export. See the Plans and Pricing

Serving leading biopharmaceutical companies globally:

UBS
Federal Trade Commission
Queensland Health
Chinese Patent Office
Covington
Accenture
Colorcon
Fuji
Merck
Moodys

Generated: February 25, 2018

DrugPatentWatch Database Preview

Dipivefrin hydrochloride - Generic Drug Details

« Back to Dashboard

What are the generic sources for dipivefrin hydrochloride and what is the scope of dipivefrin hydrochloride freedom to operate?

Dipivefrin hydrochloride
is the generic ingredient in three branded drugs marketed by Akorn, Bausch And Lomb, Falcon Pharms, and Allergan, and is included in four NDAs. Additional information is available in the individual branded drug profile pages.

There are five drug master file entries for dipivefrin hydrochloride.
Summary for dipivefrin hydrochloride

US Patents and Regulatory Information for dipivefrin hydrochloride

Applicant Tradename Generic Name Dosage NDA Approval Date TE Type RLD RS Patent No. Patent Expiration Product Substance Delist Req. Exclusivity Expiration
Falcon Pharms DIPIVEFRIN HYDROCHLORIDE dipivefrin hydrochloride SOLUTION/DROPS;OPHTHALMIC 073636-001 Jun 30, 1994 DISCN No No ➤ Sign Up ➤ Sign Up ➤ Sign Up
Allergan PROPINE dipivefrin hydrochloride SOLUTION/DROPS;OPHTHALMIC 018239-001 Approved Prior to Jan 1, 1982 DISCN No No ➤ Sign Up ➤ Sign Up ➤ Sign Up
Bausch And Lomb DIPIVEFRIN HYDROCHLORIDE dipivefrin hydrochloride SOLUTION/DROPS;OPHTHALMIC 074188-001 May 19, 1995 DISCN No No ➤ Sign Up ➤ Sign Up ➤ Sign Up
Akorn AKPRO dipivefrin hydrochloride SOLUTION/DROPS;OPHTHALMIC 074382-001 Sep 29, 1995 DISCN No No ➤ Sign Up ➤ Sign Up ➤ Sign Up
Applicant Tradename Generic Name Dosage NDA Approval Date TE Type RLD RS Patent No. Patent Expiration Product Substance Delist Req. Exclusivity Expiration

This preview shows a limited data set. Subscribe for full access, or try a Free Trial

Expired US Patents for dipivefrin hydrochloride

Applicant Tradename Generic Name Dosage NDA Approval Date Patent No. Patent Expiration
Allergan PROPINE dipivefrin hydrochloride SOLUTION/DROPS;OPHTHALMIC 018239-001 Approved Prior to Jan 1, 1982 ➤ Sign Up ➤ Sign Up
Allergan PROPINE dipivefrin hydrochloride SOLUTION/DROPS;OPHTHALMIC 018239-001 Approved Prior to Jan 1, 1982 ➤ Sign Up ➤ Sign Up
Applicant Tradename Generic Name Dosage NDA Approval Date Patent No. Patent Expiration

This preview shows a limited data set. Subscribe for full access, or try a Free Trial

For more information try a trial or see the plans and pricing

Serving hundreds of leading biopharmaceutical companies globally:

Johnson and Johnson
Dow
Colorcon
Medtronic
Mallinckrodt
Cantor Fitzgerald
Cipla
Healthtrust
Baxter

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verifification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.

botpot